Episodes

  • S5 Ep2: BRCA Gene Journey

    S5 Ep2: BRCA Gene Journey
    Jan 17 2024
    I discuss the reality of a BRCA gene mutation diagnosis with Kritsa Costello of BRCA Ireland. Krista shares her incredible, inspiring and courageous story.
    Show more Show less
    45 mins
  • S5 Ep1: Treatment of HPV; Papilocare with Dr. Damian Dexeus.

    S5 Ep1: Treatment of HPV; Papilocare with Dr. Damian Dexeus.
    Dec 27 2023
    I discuss Papilocare, a new over the counter, vaginal gel treatment for HPV with Dr. Damian Dexeus.  Dr. Damian Dexeus, Medical Director of the Women's Gynaecological Clinic in Barcelona is a specialist in Gynaecology and Obstetrics. His interests include the study of premature babies, Human papillomavirus (HPV), gynaecological cancer and breast cancer." This interview was made possible thanks to an educational grant provided by Papilocare.
    Show more Show less
    33 mins
  • S4 Ep6: ISGO: Public and Patient Involvement

    S4 Ep6: ISGO: Public and Patient Involvement
    Dec 20 2023
    "Nothing About Me Without Me": Sharon O’Toole is a senior research fellow in Trinity College Dublin working in the area of gynaecological cancer. She sits on the board of ISGO and co-founded a public and patient involvement group (ISGOPPI) within the
    society. Public and patient involvement known as PPI is where patients and members of the public get involved in research, working in partnership with healthcare professionals, scientists, allied health to improve the patient experience and to ultimately make an impact on patient outcomes. Patient advocate Bridget explains what motivates her to get involved in PPI projects, how she protects herself psychologically and emotionally whilst advocating for patients. 
    Show more Show less
    26 mins
  • S4 Ep5: ISGO: Gestational Trophoblastic Disease

    S4 Ep5: ISGO: Gestational Trophoblastic Disease
    Dec 13 2023
    Dr. John Coulter, Consultant Obstetrician and Gynaecological Oncologist and Clinical Lead of The National Gestational Trophoblastic Disease Centre at Cork University Maternity Hospital explains Gestational Trophoblastic Disease, also known as "Molar Pregnancy". Patient advocate, Rachel shares her lived experience of GTD. 
    Show more Show less
    44 mins
  • S4 Ep4: ISGO: Psychosexual Impact of Fertility Treatment and Cancer

    S4 Ep4: ISGO: Psychosexual Impact of Fertility Treatment and Cancer
    Dec 6 2023
    In this episode I speak with Tamsin who discusses the impact of fertility and cancer treatment had and still has on her relationship. I also speak with Dr. Yvonne O'Meara, Systemic Psychotherapist and Psychosocial Oncologist, who gives expert insight in to the psychosexual impact of cancer on relationships. For more information on gynaecological cancer please visit https://thisisgo.ie/
    Show more Show less
    35 mins
  • S4 Ep3: Redefining Palliative Care.

    S4 Ep3: Redefining Palliative Care.
    Oct 26 2023
    In episode 3 of The ISGO podcast we speak with Dr. Karie Dennehy and Dr. Miriam Colleran, Consultants in Palliative Medicine about the care they give to patients and their family. We then speak with Anne, a patient living with Ovarian Cancer; Anne describes what Palliative Medicine means to her. References from our discussion with Dr. Miriam Colleran: https://pubmed.ncbi.nlm.nih.gov/33547717/
    https://onlinelibrary.wiley.com/doi/10.1002/pon.5648
    Show more Show less
    35 mins
  • S4 Ep2: ISGO: Living with Ovarian Cancer and PARP Inhibitor Medications.

    S4 Ep2: ISGO: Living with Ovarian Cancer and PARP Inhibitor Medications.
    Oct 4 2023
    In episode 2 of the ISGO podcast, we speak with Dr. Dearbhaile Collins, Consultant Medical Oncologist, who explains medications known as PARP inhibitors, how they work and who they're suitable for. We then speak with Jenny, a patient living with Ovarian Cancer, and who takes a PARP inhibitor medication.
    Show more Show less
    29 mins
  • S4 Ep1: ISGO: Lived Experience of Genetic Testing.

    S4 Ep1: ISGO: Lived Experience of Genetic Testing.
    Sep 20 2023
    Genetic screening is recommended when a specific cancer appears to run in a family. BRCA and Lynch syndrome are two conditions, that when inherited, predispose someone to developing a number of different cancers. 

    BRCA 1 and BRCA 2 are tumour suppressor genes. When they function normally they stop cells in the breast, ovary and other tissues from dividing too rapidly and also repair errors that happen when cells do divide. Mutations in these genes result in a higher risk of developing cancer of ovary and breast. 

    Lynch syndrome predisposes to a number of cancers - most commonly colon, uterine and ovarian cancer. Lynch syndrome arises due to errors in a process called mismatch repair. Mismatch repair is a process of DNA repair that typically involves four different genes.
    Show more Show less
    33 mins